Literature DB >> 31340090

Roxadustat and Anemia of Chronic Kidney Disease.

Joshua Kaplan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31340090     DOI： 10.1056/NEJMe1908978

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  Harveian Oration 2020: Elucidation of molecular oxygen sensing mechanisms in human cells: implications for medicine.

Authors:  Peter J Ratcliffe
Journal:  Clin Med (Lond)       Date:  2021-12-17       Impact factor: 2.659

2.  The Endoplasmic Reticulum Cargo Receptor SURF4 Facilitates Efficient Erythropoietin Secretion.

Authors:  Zesen Lin; Richard King; Vi Tang; Greggory Myers; Ginette Balbin-Cuesta; Ann Friedman; Beth McGee; Karl Desch; Ayse Bilge Ozel; David Siemieniak; Pavan Reddy; Brian Emmer; Rami Khoriaty
Journal:  Mol Cell Biol       Date:  2020-11-06       Impact factor: 4.272

Review 3.  Treatment of Renal Anemia with Roxadustat: Advantages and Achievement.

Authors:  Zuo-Lin Li; Yan Tu; Bi-Cheng Liu
Journal:  Kidney Dis (Basel)       Date:  2020-01-10

Review 4.  HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review.

Authors:  Kiichi Hirota
Journal:  Biomedicines       Date:  2021-04-24

Review 5.  Hypoxia-Inducible Factor Stabilizers in End Stage Kidney Disease: "Can the Promise Be Kept?"

Authors:  Giuseppina Crugliano; Raffaele Serra; Nicola Ielapi; Yuri Battaglia; Giuseppe Coppolino; Davide Bolignano; Umberto Marcello Bracale; Antonio Pisani; Teresa Faga; Ashour Michael; Michele Provenzano; Michele Andreucci
Journal:  Int J Mol Sci       Date:  2021-11-22       Impact factor: 5.923

Review 6.  Challenging patient phenotypes in the management of anaemia of chronic kidney disease.

Authors:  Sheena Pramod; David S Goldfarb
Journal:  Int J Clin Pract       Date:  2021-08-12       Impact factor: 3.149

7.  Evidence for the Capability of Roxadustat (FG-4592), an Oral HIF Prolyl-Hydroxylase Inhibitor, to Perturb Membrane Ionic Currents: An Unidentified yet Important Action.

Authors:  Wei-Ting Chang; Yi-Ching Lo; Zi-Han Gao; Sheng-Nan Wu
Journal:  Int J Mol Sci       Date:  2019-11-29       Impact factor: 5.923

Review 8.  Hypoxia Pathway Proteins are Master Regulators of Erythropoiesis.

Authors:  Deepika Watts; Diana Gaete; Diego Rodriguez; David Hoogewijs; Martina Rauner; Sundary Sormendi; Ben Wielockx
Journal:  Int J Mol Sci       Date:  2020-10-30       Impact factor: 5.923

Review 9.  Erythropoietin regulation of red blood cell production: from bench to bedside and back.

Authors:  Senthil Velan Bhoopalan; Lily Jun-Shen Huang; Mitchell J Weiss
Journal:  F1000Res       Date:  2020-09-18

10.  Effect of hypoxia-inducible factor-prolyl hydroxylase inhibitors on anemia in patients with CKD: a meta-analysis of randomized controlled trials including 2804 patients.

Authors:  Bin Wang; Qing Yin; Yu-Chen Han; Min Wu; Zuo-Lin Li; Yan Tu; Le-Ting Zhou; Qing Wei; Hong Liu; Ri-Ning Tang; Jing-Yuan Cao; Lin-Li Lv; Bi-Cheng Liu
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.